BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hajishengallis G, Hajishengallis E, Kajikawa T, Wang B, Yancopoulou D, Ricklin D, Lambris JD. Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application. Semin Immunol 2016;28:285-91. [PMID: 27021500 DOI: 10.1016/j.smim.2016.03.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Tuon FF, Dantas LR, Suss PH, Tasca Ribeiro VS. Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review. Pathogens 2022;11:300. [DOI: 10.3390/pathogens11030300] [Reference Citation Analysis]
2 Hajishengallis G, Diaz PI. Porphyromonas gingivalis: Immune subversion activities and role in periodontal dysbiosis. Curr Oral Health Rep 2020;7:12-21. [PMID: 33344104 DOI: 10.1007/s40496-020-00249-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ricklin D, Mastellos DC, Reis ES, Lambris JD. The renaissance of complement therapeutics. Nat Rev Nephrol 2018;14:26-47. [PMID: 29199277 DOI: 10.1038/nrneph.2017.156] [Cited by in Crossref: 196] [Cited by in F6Publishing: 183] [Article Influence: 39.2] [Reference Citation Analysis]
4 Mödinger Y, Löffler B, Huber-lang M, Ignatius A. Complement involvement in bone homeostasis and bone disorders. Seminars in Immunology 2018;37:53-65. [DOI: 10.1016/j.smim.2018.01.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
5 Ricklin D, Lambris JD. Complement therapeutics. Semin Immunol 2016;28:205-7. [PMID: 27522923 DOI: 10.1016/j.smim.2016.07.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
6 Mastellos DC, Ricklin D, Lambris JD. Clinical promise of next-generation complement therapeutics. Nat Rev Drug Discov 2019;18:707-29. [PMID: 31324874 DOI: 10.1038/s41573-019-0031-6] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 33.0] [Reference Citation Analysis]
7 Mastellos DC, Reis ES, Ricklin D, Smith RJ, Lambris JD. Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery. Trends Immunol 2017;38:383-94. [PMID: 28416449 DOI: 10.1016/j.it.2017.03.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
8 Harris CL, Pouw RB, Kavanagh D, Sun R, Ricklin D. Developments in anti-complement therapy; from disease to clinical trial. Mol Immunol 2018;102:89-119. [PMID: 30121124 DOI: 10.1016/j.molimm.2018.06.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 10.3] [Reference Citation Analysis]
9 Mastellos DC, Reis ES, Yancopoulou D, Hajishengallis G, Ricklin D, Lambris JD. From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage. Immunobiology 2016;221:1046-57. [PMID: 27353192 DOI: 10.1016/j.imbio.2016.06.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
10 Bowen WH, Burne RA, Wu H, Koo H. Oral Biofilms: Pathogens, Matrix, and Polymicrobial Interactions in Microenvironments. Trends Microbiol 2018;26:229-42. [PMID: 29097091 DOI: 10.1016/j.tim.2017.09.008] [Cited by in Crossref: 242] [Cited by in F6Publishing: 204] [Article Influence: 48.4] [Reference Citation Analysis]
11 Gavriilaki E, Brodsky RA. Complementopathies and precision medicine. J Clin Invest 2020;130:2152-63. [PMID: 32310222 DOI: 10.1172/JCI136094] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 36.0] [Reference Citation Analysis]
12 Wang Y, Lai P, Chen X, He C, Huang X, Geng S, Luo C, Wu S, Ling W, Zhong L, Lu Z, Li P, Weng J, Du X. Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg. Sci Rep 2017;7:3603. [PMID: 28620195 DOI: 10.1038/s41598-017-03700-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
13 Palioto DB, Finoti LS, Kinane DF, Benakanakere M. Epigenetic and inflammatory events in experimental periodontitis following systemic microbial challenge. J Clin Periodontol 2019;46:819-29. [PMID: 31131910 DOI: 10.1111/jcpe.13151] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
14 Mastellos DC, Reis ES, Yancopoulou D, Risitano AM, Lambris JD. Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal Hemoglobinuria. Semin Hematol 2018;55:167-75. [PMID: 30032754 DOI: 10.1053/j.seminhematol.2018.02.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
15 Mata K, Nobre AVV, Felix Silva PH, Oliezer RS, Fernandes C, Amaral J, Ramos J, Constante Gabriel Del-Arco M, Messora MR, Tanus-Santos JE, Gerlach RF, Salvador SL. A new mixed model of periodontitis-induced preeclampsia: A pilot study. J Periodontal Res 2021;56:726-34. [PMID: 33686671 DOI: 10.1111/jre.12869] [Reference Citation Analysis]
16 Thi MTT, Wibowo D, Rehm BHA. Pseudomonas aeruginosa Biofilms. Int J Mol Sci 2020;21:E8671. [PMID: 33212950 DOI: 10.3390/ijms21228671] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
17 Jevtic S, Sengar AS, Salter MW, McLaurin J. The role of the immune system in Alzheimer disease: Etiology and treatment. Ageing Res Rev 2017;40:84-94. [PMID: 28941639 DOI: 10.1016/j.arr.2017.08.005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 74] [Article Influence: 18.4] [Reference Citation Analysis]
18 Koo H, Allan RN, Howlin RP, Stoodley P, Hall-Stoodley L. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rev Microbiol 2017;15:740-55. [PMID: 28944770 DOI: 10.1038/nrmicro.2017.99] [Cited by in Crossref: 553] [Cited by in F6Publishing: 469] [Article Influence: 110.6] [Reference Citation Analysis]
19 Huang J, Cai X, Ou Y, Fan L, Zhou Y, Wang Y. Protective roles of FICZ and aryl hydrocarbon receptor axis on alveolar bone loss and inflammation in experimental periodontitis. J Clin Periodontol 2019;46:882-93. [PMID: 31286538 DOI: 10.1111/jcpe.13166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
20 Alvarez C, Monasterio G, Cavalla F, Córdova LA, Hernández M, Heymann D, Garlet GP, Sorsa T, Pärnänen P, Lee HM, Golub LM, Vernal R, Kantarci A. Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms. Front Immunol 2019;10:1664. [PMID: 31379856 DOI: 10.3389/fimmu.2019.01664] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
21 Núñez K, Thevenot P, Alfadhli A, Cohen A. Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function. Int J Mol Sci 2018;19:E1750. [PMID: 29899265 DOI: 10.3390/ijms19061750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
22 Leira Y, Mascarenhas P, Blanco J, Sobrino T, Mendes JJ, Machado V, Botelho J. Network Protein Interaction in the Link between Stroke and Periodontitis Interplay: A Pilot Bioinformatic Analysis. Genes (Basel) 2021;12:787. [PMID: 34065604 DOI: 10.3390/genes12050787] [Reference Citation Analysis]
23 Hajishengallis G. New developments in neutrophil biology and periodontitis. Periodontol 2000 2020;82:78-92. [DOI: 10.1111/prd.12313] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
24 Feres M, Louzoun Y, Haber S, Faveri M, Figueiredo LC, Levin L. Support vector machine-based differentiation between aggressive and chronic periodontitis using microbial profiles. International Dental Journal 2018;68:39-46. [DOI: 10.1111/idj.12326] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
25 Pockpa ZA, Struillou X, Coulibaly NT, Weber M, Soueidan A, Badran Z. Potential relationship between periodontal diseases and eye diseases. Med Hypotheses 2017;99:63-6. [PMID: 28110701 DOI: 10.1016/j.mehy.2016.12.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Qasim SSB, Al-Otaibi D, Al-Jasser R, Gul SS, Zafar MS. An Evidence-Based Update on the Molecular Mechanisms Underlying Periodontal Diseases. Int J Mol Sci 2020;21:E3829. [PMID: 32481582 DOI: 10.3390/ijms21113829] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
27 van Greevenbroek MM, Schalkwijk CG, Stehouwer CD. Dysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advances. F1000Res 2016;5:F1000 Faculty Rev-2515. [PMID: 27803798 DOI: 10.12688/f1000research.8971.1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
28 Bleuez C, Koch WF, Urbach C, Hollfelder F, Jermutus L. Exploiting protease activation for therapy. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.03.011] [Reference Citation Analysis]
29 Zhang D, Xu T, Xu Q, Dong Q, Luo Y, Gao L, Pan Y. Expression profile of macrophage migration inhibitory factor in periodontitis. Arch Oral Biol 2021;122:105003. [PMID: 33279833 DOI: 10.1016/j.archoralbio.2020.105003] [Reference Citation Analysis]
30 Nogueras-Ortiz CJ, Mahairaki V, Delgado-Peraza F, Das D, Avgerinos K, Eren E, Hentschel M, Goetzl EJ, Mattson MP, Kapogiannis D. Astrocyte- and Neuron-Derived Extracellular Vesicles from Alzheimer's Disease Patients Effect Complement-Mediated Neurotoxicity. Cells 2020;9:E1618. [PMID: 32635578 DOI: 10.3390/cells9071618] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
31 Ebersole JL, Dawson D, Emecen-huja P, Nagarajan R, Howard K, Grady ME, Thompson K, Peyyala R, Al-attar A, Lethbridge K, Kirakodu S, Gonzalez OA. The periodontal war: microbes and immunity. Periodontol 2000 2017;75:52-115. [DOI: 10.1111/prd.12222] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 14.4] [Reference Citation Analysis]
32 Hajishengallis G, Reis ES, Mastellos DC, Ricklin D, Lambris JD. Novel mechanisms and functions of complement. Nat Immunol 2017;18:1288-98. [PMID: 29144501 DOI: 10.1038/ni.3858] [Cited by in Crossref: 200] [Cited by in F6Publishing: 192] [Article Influence: 40.0] [Reference Citation Analysis]
33 Ha DY, Jung JS, Choi GH, Ji S. Polarization of human gingival fibroblasts by Th1-, Th2-, Th17-, and Treg-derived cytokines. J Periodontal Res 2022. [PMID: 35212397 DOI: 10.1111/jre.12978] [Reference Citation Analysis]
34 Primikyri A, Papanastasiou M, Sarigiannis Y, Koutsogiannaki S, Reis ES, Tuplano JV, Resuello RR, Nilsson B, Ricklin D, Lambris JD. Method development and validation for the quantitation of the complement inhibitor Cp40 in human and cynomolgus monkey plasma by UPLC-ESI-MS. J Chromatogr B Analyt Technol Biomed Life Sci 2017;1041-1042:19-26. [PMID: 27992787 DOI: 10.1016/j.jchromb.2016.12.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
35 Ricklin D, Reis ES, Mastellos DC, Gros P, Lambris JD. Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense. Immunol Rev 2016;274:33-58. [PMID: 27782325 DOI: 10.1111/imr.12500] [Cited by in Crossref: 139] [Cited by in F6Publishing: 130] [Article Influence: 27.8] [Reference Citation Analysis]